Pub. Date : 1990 Oct
PMID : 1965317
7 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Comparative in-vitro activity of piperacillin and piperacillin plus tazobactam towards beta-lactamase producing clinical isolates. | Piperacillin | beta-lactamase TEM-1 | Haemophilus influenzae |
| 2 | Comparative in-vitro activity of piperacillin and piperacillin plus tazobactam towards beta-lactamase producing clinical isolates. | Piperacillin | beta-lactamase TEM-1 | Haemophilus influenzae |
| 3 | Comparative in-vitro activity of piperacillin and piperacillin plus tazobactam towards beta-lactamase producing clinical isolates. | Tazobactam | beta-lactamase TEM-1 | Haemophilus influenzae |
| 4 | The authors evaluated the in-vitro antibacterial activity of piperacillin alone and of piperacillin combined with tazobactam, a new beta-lactamase inhibitor, on 398 clinical isolates, both Gram-positive and Gram-negative. | Tazobactam | beta-lactamase TEM-1 | Haemophilus influenzae |
| 5 | The vast majority of the microorganisms tested had reduced susceptibility to piperacillin (minimum inhibitory concentration (MIC) range 0.12- greater than 256 mg/l) due to beta-lactamase production. | Piperacillin | beta-lactamase TEM-1 | Haemophilus influenzae |
| 6 | In the latter, the combination of piperacillin/tazobactam was active only if the strains showed beta-lactamase production. | Piperacillin | beta-lactamase TEM-1 | Haemophilus influenzae |
| 7 | In the latter, the combination of piperacillin/tazobactam was active only if the strains showed beta-lactamase production. | Tazobactam | beta-lactamase TEM-1 | Haemophilus influenzae |